obesity drug news today glp-1 october 2025 health pharma drugs Outlook for obesity in 2025: more Rhode Island considers ending Medicaid
Description
Transl Oncol
A scoping review of GLP-1 receptor agonists: Are they associated with increased gastric contents, regurgitation, and aspiration events
Suppressing glucagon helps prevent blood sugar from rising too high
Trials so far have shown superiority of GLP-1 receptor agonists and SGLT2 inhibitors in MACE reduction when compared to DPP-4 inhibitors
Sugerman HJ, DeMaria EJ, Felton WL III, Nakatsuka M, Sismanis A
